Gabapentin
Product Images NDC 45865-405

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (405)

Gabapentin Tablets 800mg packaging label from Medsource Pharmaceuticals. The label states it is a generic formulation for neurontin, with 90 tablets per package. Additional details include tablet shape and color (white, oval), directions to avoid alcohol, and warnings about possible dizziness or drowsiness. Directions for daily dosage are partially visible but not fully legible.*

FDA Label Image

Equation.jpg (Equation)

An illustrated formula for estimating creatinine clearance (CLCr) that includes variables for age, weight, serum creatinine, and a factor adjustment for female patients. This is a common pharmacokinetic calculation used in clinical settings.*

FDA Label Image

Fig2.jpg (Fig 2)

A line graph showing mean pain score over 7 weeks for placebo and Gabapentin dosed at 1800 mg/day and 2400 mg/day. The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain score values from 0 to 10. Gabapentin groups show a decline in pain score compared to placebo.*

FDA Label Image

Fig3.jpg (Fig 3)

A bar chart titled 'Proportion of Responders (patients with > 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results of two studies. Study 1 compares placebo (PBO) at 12% and Gabapentin (GBP) 3600 mg at 29%. Study 2 compares placebo at 14%, GBP 1800 mg at 32%, and GBP 2400 mg at 34%, with significance levels indicated (** p < 0.01, *** p < 0.001).*

FDA Label Image

Fig4.jpg (Fig 4)

A scatter plot showing difference percentages versus daily dose in milligrams for Gabapentin across three studies labeled a, b, and c. Each study is represented by different markers (filled black square, gray square, and white square). The graph compares differences at daily doses of approximately 600, 900, 1200, and 1800 mg.*

FDA Label Image

Fig1.jpg (Image 01)

A line graph showing mean pain scores over an 8-week period, including a 4-week dose titration period and a 4-week fixed dose period. The graph compares placebo and Gabapentin, 3600 mg/day, with Gabapentin showing a decreasing pain score trend compared to placebo.*

FDA Label Image

Logo.jpg (Logo 01)

FDA Label Image

Logo.jpg (Logo)

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of the active ingredient gabapentin, showing its amino and carboxylic acid functional groups attached to a cyclohexane ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.